Global Opioid-Induced Constipation (OIC) Treatment Market Size, Status and Forecast 2024-2031

Report ID: 1012807 | Published Date: Jan 2025 | No. of Page: 96 | Base Year: 2024 | Rating: 4.3 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Opioid-Induced Constipation (OIC) Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 Oral
        1.2.3 Parenteral (Subcutaneous Injection)
    1.3 Market by Application
        1.3.1 Global Opioid-Induced Constipation (OIC) Treatment Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 Drug Store
        1.3.3 Independent Pharmacies
        1.3.4 Hospital Pharmacies
    1.4 Study Objectives
    1.5 Years Considered

2 Global Growth Trends
    2.1 Global Opioid-Induced Constipation (OIC) Treatment Market Perspective (2016-2027)
    2.2 Opioid-Induced Constipation (OIC) Treatment Growth Trends by Regions
        2.2.1 Opioid-Induced Constipation (OIC) Treatment Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 Opioid-Induced Constipation (OIC) Treatment Historic Market Share by Regions (2016-2021)
        2.2.3 Opioid-Induced Constipation (OIC) Treatment Forecasted Market Size by Regions (2022-2027)
    2.3 Opioid-Induced Constipation (OIC) Treatment Industry Dynamic
        2.3.1 Opioid-Induced Constipation (OIC) Treatment Market Trends
        2.3.2 Opioid-Induced Constipation (OIC) Treatment Market Drivers
        2.3.3 Opioid-Induced Constipation (OIC) Treatment Market Challenges
        2.3.4 Opioid-Induced Constipation (OIC) Treatment Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top Opioid-Induced Constipation (OIC) Treatment Players by Revenue
        3.1.1 Global Top Opioid-Induced Constipation (OIC) Treatment Players by Revenue (2016-2021)
        3.1.2 Global Opioid-Induced Constipation (OIC) Treatment Revenue Market Share by Players (2016-2021)
    3.2 Global Opioid-Induced Constipation (OIC) Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by Opioid-Induced Constipation (OIC) Treatment Revenue
    3.4 Global Opioid-Induced Constipation (OIC) Treatment Market Concentration Ratio
        3.4.1 Global Opioid-Induced Constipation (OIC) Treatment Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Opioid-Induced Constipation (OIC) Treatment Revenue in 2020
    3.5 Opioid-Induced Constipation (OIC) Treatment Key Players Head office and Area Served
    3.6 Key Players Opioid-Induced Constipation (OIC) Treatment Product Solution and Service
    3.7 Date of Enter into Opioid-Induced Constipation (OIC) Treatment Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 Opioid-Induced Constipation (OIC) Treatment Breakdown Data by Type
    4.1 Global Opioid-Induced Constipation (OIC) Treatment Historic Market Size by Type (2016-2021)
    4.2 Global Opioid-Induced Constipation (OIC) Treatment Forecasted Market Size by Type (2022-2027)

5 Opioid-Induced Constipation (OIC) Treatment Breakdown Data by Application
    5.1 Global Opioid-Induced Constipation (OIC) Treatment Historic Market Size by Application (2016-2021)
    5.2 Global Opioid-Induced Constipation (OIC) Treatment Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America Opioid-Induced Constipation (OIC) Treatment Market Size (2016-2027)
    6.2 North America Opioid-Induced Constipation (OIC) Treatment Market Size by Type
        6.2.1 North America Opioid-Induced Constipation (OIC) Treatment Market Size by Type (2016-2021)
        6.2.2 North America Opioid-Induced Constipation (OIC) Treatment Market Size by Type (2022-2027)
        6.2.3 North America Opioid-Induced Constipation (OIC) Treatment Market Size by Type (2016-2027)
    6.3 North America Opioid-Induced Constipation (OIC) Treatment Market Size by Application
        6.3.1 North America Opioid-Induced Constipation (OIC) Treatment Market Size by Application (2016-2021)
        6.3.2 North America Opioid-Induced Constipation (OIC) Treatment Market Size by Application (2022-2027)
        6.3.3 North America Opioid-Induced Constipation (OIC) Treatment Market Size by Application (2016-2027)
    6.4 North America Opioid-Induced Constipation (OIC) Treatment Market Size by Country
        6.4.1 North America Opioid-Induced Constipation (OIC) Treatment Market Size by Country (2016-2021)
        6.4.2 North America Opioid-Induced Constipation (OIC) Treatment Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe Opioid-Induced Constipation (OIC) Treatment Market Size (2016-2027)
    7.2 Europe Opioid-Induced Constipation (OIC) Treatment Market Size by Type
        7.2.1 Europe Opioid-Induced Constipation (OIC) Treatment Market Size by Type (2016-2021)
        7.2.2 Europe Opioid-Induced Constipation (OIC) Treatment Market Size by Type (2022-2027)
        7.2.3 Europe Opioid-Induced Constipation (OIC) Treatment Market Size by Type (2016-2027)
    7.3 Europe Opioid-Induced Constipation (OIC) Treatment Market Size by Application
        7.3.1 Europe Opioid-Induced Constipation (OIC) Treatment Market Size by Application (2016-2021)
        7.3.2 Europe Opioid-Induced Constipation (OIC) Treatment Market Size by Application (2022-2027)
        7.3.3 Europe Opioid-Induced Constipation (OIC) Treatment Market Size by Application (2016-2027)
    7.4 Europe Opioid-Induced Constipation (OIC) Treatment Market Size by Country
        7.4.1 Europe Opioid-Induced Constipation (OIC) Treatment Market Size by Country (2016-2021)
        7.4.2 Europe Opioid-Induced Constipation (OIC) Treatment Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific Opioid-Induced Constipation (OIC) Treatment Market Size (2016-2027)
    8.2 Asia-Pacific Opioid-Induced Constipation (OIC) Treatment Market Size by Type
        8.2.1 Asia-Pacific Opioid-Induced Constipation (OIC) Treatment Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific Opioid-Induced Constipation (OIC) Treatment Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific Opioid-Induced Constipation (OIC) Treatment Market Size by Type (2016-2027)
    8.3 Asia-Pacific Opioid-Induced Constipation (OIC) Treatment Market Size by Application
        8.3.1 Asia-Pacific Opioid-Induced Constipation (OIC) Treatment Market Size by Application (2016-2021)
        8.3.2 Asia-Pacific Opioid-Induced Constipation (OIC) Treatment Market Size by Application (2022-2027)
        8.3.3 Asia-Pacific Opioid-Induced Constipation (OIC) Treatment Market Size by Application (2016-2027)
    8.4 Asia-Pacific Opioid-Induced Constipation (OIC) Treatment Market Size by Region
        8.4.1 Asia-Pacific Opioid-Induced Constipation (OIC) Treatment Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific Opioid-Induced Constipation (OIC) Treatment Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America Opioid-Induced Constipation (OIC) Treatment Market Size (2016-2027)
    9.2 Latin America Opioid-Induced Constipation (OIC) Treatment Market Size by Type
        9.2.1 Latin America Opioid-Induced Constipation (OIC) Treatment Market Size by Type (2016-2021)
        9.2.2 Latin America Opioid-Induced Constipation (OIC) Treatment Market Size by Type (2022-2027)
        9.2.3 Latin America Opioid-Induced Constipation (OIC) Treatment Market Size by Type (2016-2027)
    9.3 Latin America Opioid-Induced Constipation (OIC) Treatment Market Size by Application
        9.3.1 Latin America Opioid-Induced Constipation (OIC) Treatment Market Size by Application (2016-2021)
        9.3.2 Latin America Opioid-Induced Constipation (OIC) Treatment Market Size by Application (2022-2027)
        9.3.3 Latin America Opioid-Induced Constipation (OIC) Treatment Market Size by Application (2016-2027)
    9.4 Latin America Opioid-Induced Constipation (OIC) Treatment Market Size by Country
        9.4.1 Latin America Opioid-Induced Constipation (OIC) Treatment Market Size by Country (2016-2021)
        9.4.2 Latin America Opioid-Induced Constipation (OIC) Treatment Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa Opioid-Induced Constipation (OIC) Treatment Market Size (2016-2027)
    10.2 Middle East & Africa Opioid-Induced Constipation (OIC) Treatment Market Size by Type
        10.2.1 Middle East & Africa Opioid-Induced Constipation (OIC) Treatment Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa Opioid-Induced Constipation (OIC) Treatment Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa Opioid-Induced Constipation (OIC) Treatment Market Size by Type (2016-2027)
    10.3 Middle East & Africa Opioid-Induced Constipation (OIC) Treatment Market Size by Application
        10.3.1 Middle East & Africa Opioid-Induced Constipation (OIC) Treatment Market Size by Application (2016-2021)
        10.3.2 Middle East & Africa Opioid-Induced Constipation (OIC) Treatment Market Size by Application (2022-2027)
        10.3.3 Middle East & Africa Opioid-Induced Constipation (OIC) Treatment Market Size by Application (2016-2027)
    10.4 Middle East & Africa Opioid-Induced Constipation (OIC) Treatment Market Size by Country
        10.4.1 Middle East & Africa Opioid-Induced Constipation (OIC) Treatment Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa Opioid-Induced Constipation (OIC) Treatment Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 GlaxoSmithKline
        11.1.1 GlaxoSmithKline Company Details
        11.1.2 GlaxoSmithKline Business Overview
        11.1.3 GlaxoSmithKline Opioid-Induced Constipation (OIC) Treatment Introduction
        11.1.4 GlaxoSmithKline Revenue in Opioid-Induced Constipation (OIC) Treatment Business (2016-2021)
        11.1.5 GlaxoSmithKline Recent Development
    11.2 AstraZeneca
        11.2.1 AstraZeneca Company Details
        11.2.2 AstraZeneca Business Overview
        11.2.3 AstraZeneca Opioid-Induced Constipation (OIC) Treatment Introduction
        11.2.4 AstraZeneca Revenue in Opioid-Induced Constipation (OIC) Treatment Business (2016-2021)
        11.2.5 AstraZeneca Recent Development
    11.3 Pfizer
        11.3.1 Pfizer Company Details
        11.3.2 Pfizer Business Overview
        11.3.3 Pfizer Opioid-Induced Constipation (OIC) Treatment Introduction
        11.3.4 Pfizer Revenue in Opioid-Induced Constipation (OIC) Treatment Business (2016-2021)
        11.3.5 Pfizer Recent Development
    11.4 S.L.A. Pharma
        11.4.1 S.L.A. Pharma Company Details
        11.4.2 S.L.A. Pharma Business Overview
        11.4.3 S.L.A. Pharma Opioid-Induced Constipation (OIC) Treatment Introduction
        11.4.4 S.L.A. Pharma Revenue in Opioid-Induced Constipation (OIC) Treatment Business (2016-2021)
        11.4.5 S.L.A. Pharma Recent Development
    11.5 AIKO Biotechnology
        11.5.1 AIKO Biotechnology Company Details
        11.5.2 AIKO Biotechnology Business Overview
        11.5.3 AIKO Biotechnology Opioid-Induced Constipation (OIC) Treatment Introduction
        11.5.4 AIKO Biotechnology Revenue in Opioid-Induced Constipation (OIC) Treatment Business (2016-2021)
        11.5.5 AIKO Biotechnology Recent Development
    11.6 Cubist Pharmaceuticals
        11.6.1 Cubist Pharmaceuticals Company Details
        11.6.2 Cubist Pharmaceuticals Business Overview
        11.6.3 Cubist Pharmaceuticals Opioid-Induced Constipation (OIC) Treatment Introduction
        11.6.4 Cubist Pharmaceuticals Revenue in Opioid-Induced Constipation (OIC) Treatment Business (2016-2021)
        11.6.5 Cubist Pharmaceuticals Recent Development
    11.7 Salix Pharmaceuticals
        11.7.1 Salix Pharmaceuticals Company Details
        11.7.2 Salix Pharmaceuticals Business Overview
        11.7.3 Salix Pharmaceuticals Opioid-Induced Constipation (OIC) Treatment Introduction
        11.7.4 Salix Pharmaceuticals Revenue in Opioid-Induced Constipation (OIC) Treatment Business (2016-2021)
        11.7.5 Salix Pharmaceuticals Recent Development
    11.8 Takeda Pharmaceutical
        11.8.1 Takeda Pharmaceutical Company Details
        11.8.2 Takeda Pharmaceutical Business Overview
        11.8.3 Takeda Pharmaceutical Opioid-Induced Constipation (OIC) Treatment Introduction
        11.8.4 Takeda Pharmaceutical Revenue in Opioid-Induced Constipation (OIC) Treatment Business (2016-2021)
        11.8.5 Takeda Pharmaceutical Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Opioid-Induced Constipation (OIC) Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of Oral
    Table 3. Key Players of Parenteral (Subcutaneous Injection)
    Table 4. Global Opioid-Induced Constipation (OIC) Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 5. Global Opioid-Induced Constipation (OIC) Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 6. Global Opioid-Induced Constipation (OIC) Treatment Market Size by Regions (2016-2021) & (US$ Million)
    Table 7. Global Opioid-Induced Constipation (OIC) Treatment Market Share by Regions (2016-2021)
    Table 8. Global Opioid-Induced Constipation (OIC) Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 9. Global Opioid-Induced Constipation (OIC) Treatment Market Share by Regions (2022-2027)
    Table 10. Opioid-Induced Constipation (OIC) Treatment Market Trends
    Table 11. Opioid-Induced Constipation (OIC) Treatment Market Drivers
    Table 12. Opioid-Induced Constipation (OIC) Treatment Market Challenges
    Table 13. Opioid-Induced Constipation (OIC) Treatment Market Restraints
    Table 14. Global Opioid-Induced Constipation (OIC) Treatment Revenue by Players (2016-2021) & (US$ Million)
    Table 15. Global Opioid-Induced Constipation (OIC) Treatment Market Share by Players (2016-2021)
    Table 16. Global Top Opioid-Induced Constipation (OIC) Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Opioid-Induced Constipation (OIC) Treatment as of 2020)
    Table 17. Ranking of Global Top Opioid-Induced Constipation (OIC) Treatment Companies by Revenue (US$ Million) in 2020
    Table 18. Global 5 Largest Players Market Share by Opioid-Induced Constipation (OIC) Treatment Revenue (CR5 and HHI) & (2016-2021)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Opioid-Induced Constipation (OIC) Treatment Product Solution and Service
    Table 21. Date of Enter into Opioid-Induced Constipation (OIC) Treatment Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Opioid-Induced Constipation (OIC) Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 24. Global Opioid-Induced Constipation (OIC) Treatment Revenue Market Share by Type (2016-2021)
    Table 25. Global Opioid-Induced Constipation (OIC) Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 26. Global Opioid-Induced Constipation (OIC) Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 27. Global Opioid-Induced Constipation (OIC) Treatment Market Size Share by Application (2016-2021) & (US$ Million)
    Table 28. Global Opioid-Induced Constipation (OIC) Treatment Revenue Market Share by Application (2016-2021)
    Table 29. Global Opioid-Induced Constipation (OIC) Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 30. Global Opioid-Induced Constipation (OIC) Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 31. North America Opioid-Induced Constipation (OIC) Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 32. North America Opioid-Induced Constipation (OIC) Treatment Market Size by Type (2022-2027) & (US$ Million)
    Table 33. North America Opioid-Induced Constipation (OIC) Treatment Market Size by Application (2016-2021) (US$ Million)
    Table 34. North America Opioid-Induced Constipation (OIC) Treatment Market Size by Application (2022-2027) & (US$ Million)
    Table 35. North America Opioid-Induced Constipation (OIC) Treatment Market Size by Country (2016-2021) & (US$ Million) 
    Table 36. North America Opioid-Induced Constipation (OIC) Treatment Market Size by Country (2022-2027) & (US$ Million) 
    Table 37. Europe Opioid-Induced Constipation (OIC) Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 38. Europe Opioid-Induced Constipation (OIC) Treatment Market Size by Type (2022-2027) & (US$ Million)
    Table 39. Europe Opioid-Induced Constipation (OIC) Treatment Market Size by Application (2016-2021) (US$ Million)
    Table 40. Europe Opioid-Induced Constipation (OIC) Treatment Market Size by Application (2022-2027) & (US$ Million)
    Table 41. Europe Opioid-Induced Constipation (OIC) Treatment Market Size by Country (2016-2021) & (US$ Million) 
    Table 42. Europe Opioid-Induced Constipation (OIC) Treatment Market Size by Country (2022-2027) & (US$ Million) 
    Table 43. Asia-Pacific Opioid-Induced Constipation (OIC) Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 44. Asia-Pacific Opioid-Induced Constipation (OIC) Treatment Market Size by Type (2022-2027) & (US$ Million)
    Table 45. Asia-Pacific Opioid-Induced Constipation (OIC) Treatment Market Size by Application (2016-2021) (US$ Million)
    Table 46. Asia-Pacific Opioid-Induced Constipation (OIC) Treatment Market Size by Application (2022-2027) & (US$ Million)
    Table 47. Asia-Pacific Opioid-Induced Constipation (OIC) Treatment Market Size by Region (2016-2021) & (US$ Million) 
    Table 48. Asia-Pacific Opioid-Induced Constipation (OIC) Treatment Market Size by Region (2022-2027) & (US$ Million) 
    Table 49. Latin America Opioid-Induced Constipation (OIC) Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 50. Latin America Opioid-Induced Constipation (OIC) Treatment Market Size by Type (2022-2027) & (US$ Million)
    Table 51. Latin America Opioid-Induced Constipation (OIC) Treatment Market Size by Application (2016-2021) (US$ Million)
    Table 52. Latin America Opioid-Induced Constipation (OIC) Treatment Market Size by Application (2022-2027) & (US$ Million)
    Table 53. Latin America Opioid-Induced Constipation (OIC) Treatment Market Size by Country (2016-2021) & (US$ Million) 
    Table 54. Latin America Opioid-Induced Constipation (OIC) Treatment Market Size by Country (2022-2027) & (US$ Million) 
    Table 55. Middle East & Africa Opioid-Induced Constipation (OIC) Treatment Market Size by Type (2016-2021) (US$ Million)
    Table 56. Middle East & Africa Opioid-Induced Constipation (OIC) Treatment Market Size by Type (2022-2027) & (US$ Million)
    Table 57. Middle East & Africa Opioid-Induced Constipation (OIC) Treatment Market Size by Application (2016-2021) (US$ Million)
    Table 58. Middle East & Africa Opioid-Induced Constipation (OIC) Treatment Market Size by Application (2022-2027) & (US$ Million)
    Table 59. Middle East & Africa Opioid-Induced Constipation (OIC) Treatment Market Size by Country (2016-2021) & (US$ Million) 
    Table 60. Middle East & Africa Opioid-Induced Constipation (OIC) Treatment Market Size by Country (2022-2027) & (US$ Million) 
    Table 61. GlaxoSmithKline Company Details
    Table 62. GlaxoSmithKline Business Overview
    Table 63. GlaxoSmithKline Opioid-Induced Constipation (OIC) Treatment Product
    Table 64. GlaxoSmithKline Revenue in Opioid-Induced Constipation (OIC) Treatment Business (2016-2021) & (US$ Million)
    Table 65. GlaxoSmithKline Recent Development
    Table 66. AstraZeneca Company Details
    Table 67. AstraZeneca Business Overview
    Table 68. AstraZeneca Opioid-Induced Constipation (OIC) Treatment Product
    Table 69. AstraZeneca Revenue in Opioid-Induced Constipation (OIC) Treatment Business (2016-2021) & (US$ Million)
    Table 70. AstraZeneca Recent Development
    Table 71. Pfizer Company Details
    Table 72. Pfizer Business Overview
    Table 73. Pfizer Opioid-Induced Constipation (OIC) Treatment Product
    Table 74. Pfizer Revenue in Opioid-Induced Constipation (OIC) Treatment Business (2016-2021) & (US$ Million)
    Table 75. Pfizer Recent Development
    Table 76. S.L.A. Pharma Company Details
    Table 77. S.L.A. Pharma Business Overview
    Table 78. S.L.A. Pharma Opioid-Induced Constipation (OIC) Treatment Product
    Table 79. S.L.A. Pharma Revenue in Opioid-Induced Constipation (OIC) Treatment Business (2016-2021) & (US$ Million)
    Table 80. S.L.A. Pharma Recent Development
    Table 81. AIKO Biotechnology Company Details
    Table 82. AIKO Biotechnology Business Overview
    Table 83. AIKO Biotechnology Opioid-Induced Constipation (OIC) Treatment Product
    Table 84. AIKO Biotechnology Revenue in Opioid-Induced Constipation (OIC) Treatment Business (2016-2021) & (US$ Million)
    Table 85. AIKO Biotechnology Recent Development
    Table 86. Cubist Pharmaceuticals Company Details
    Table 87. Cubist Pharmaceuticals Business Overview
    Table 88. Cubist Pharmaceuticals Opioid-Induced Constipation (OIC) Treatment Product
    Table 89. Cubist Pharmaceuticals Revenue in Opioid-Induced Constipation (OIC) Treatment Business (2016-2021) & (US$ Million)
    Table 90. Cubist Pharmaceuticals Recent Development
    Table 91. Salix Pharmaceuticals Company Details
    Table 92. Salix Pharmaceuticals Business Overview
    Table 93. Salix Pharmaceuticals Opioid-Induced Constipation (OIC) Treatment Product
    Table 94. Salix Pharmaceuticals Revenue in Opioid-Induced Constipation (OIC) Treatment Business (2016-2021) & (US$ Million)
    Table 95. Salix Pharmaceuticals Recent Development
    Table 96. Takeda Pharmaceutical Company Details
    Table 97. Takeda Pharmaceutical Business Overview
    Table 98. Takeda Pharmaceutical Revenue in Opioid-Induced Constipation (OIC) Treatment Business (2016-2021) & (US$ Million)
    Table 99. Takeda Pharmaceutical Recent Development
    Table 100. Research Programs/Design for This Report
    Table 101. Key Data Information from Secondary Sources
    Table 102. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Opioid-Induced Constipation (OIC) Treatment Market Share by Type: 2020 VS 2027
    Figure 2. Oral Features
    Figure 3. Parenteral (Subcutaneous Injection) Features
    Figure 4. Global Opioid-Induced Constipation (OIC) Treatment Market Share by Application: 2020 VS 2027
    Figure 5. Drug Store Case Studies
    Figure 6. Independent Pharmacies Case Studies
    Figure 7. Hospital Pharmacies Case Studies
    Figure 8. Opioid-Induced Constipation (OIC) Treatment Report Years Considered
    Figure 9. Global Opioid-Induced Constipation (OIC) Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 10. Global Opioid-Induced Constipation (OIC) Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 11. Global Opioid-Induced Constipation (OIC) Treatment Market Share by Regions: 2020 VS 2027
    Figure 12. Global Opioid-Induced Constipation (OIC) Treatment Market Share by Regions (2022-2027)
    Figure 13. Global Opioid-Induced Constipation (OIC) Treatment Market Share by Players in 2020
    Figure 14. Global Top Opioid-Induced Constipation (OIC) Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Opioid-Induced Constipation (OIC) Treatment as of 2020
    Figure 15. The Top 10 and 5 Players Market Share by Opioid-Induced Constipation (OIC) Treatment Revenue in 2020
    Figure 16. Global Opioid-Induced Constipation (OIC) Treatment Revenue Market Share by Type (2016-2021)
    Figure 17. Global Opioid-Induced Constipation (OIC) Treatment Revenue Market Share by Type (2022-2027)
    Figure 18. North America Opioid-Induced Constipation (OIC) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 19. North America Opioid-Induced Constipation (OIC) Treatment Market Share by Type (2016-2027)
    Figure 20. North America Opioid-Induced Constipation (OIC) Treatment Market Share by Application (2016-2027)
    Figure 21. North America Opioid-Induced Constipation (OIC) Treatment Market Share by Country (2016-2027)
    Figure 22. United States Opioid-Induced Constipation (OIC) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 23. Canada Opioid-Induced Constipation (OIC) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 24. Europe Opioid-Induced Constipation (OIC) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 25. Europe Opioid-Induced Constipation (OIC) Treatment Market Share by Type (2016-2027)
    Figure 26. Europe Opioid-Induced Constipation (OIC) Treatment Market Share by Application (2016-2027)
    Figure 27. Europe Opioid-Induced Constipation (OIC) Treatment Market Share by Country (2016-2027)
    Figure 28. Germany Opioid-Induced Constipation (OIC) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 29. France Opioid-Induced Constipation (OIC) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 30. U.K. Opioid-Induced Constipation (OIC) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 31. Italy Opioid-Induced Constipation (OIC) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 32. Russia Opioid-Induced Constipation (OIC) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 33. Nordic Opioid-Induced Constipation (OIC) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 34. Asia-Pacific Opioid-Induced Constipation (OIC) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 35. Asia-Pacific Opioid-Induced Constipation (OIC) Treatment Market Share by Type (2016-2027)
    Figure 36. Asia-Pacific Opioid-Induced Constipation (OIC) Treatment Market Share by Application (2016-2027)
    Figure 37. Asia-Pacific Opioid-Induced Constipation (OIC) Treatment Market Share by Region (2016-2027)
    Figure 38. China Opioid-Induced Constipation (OIC) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 39. Japan Opioid-Induced Constipation (OIC) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 40. South Korea Opioid-Induced Constipation (OIC) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 41. Southeast Asia Opioid-Induced Constipation (OIC) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 42. India Opioid-Induced Constipation (OIC) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 43. Australia Opioid-Induced Constipation (OIC) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 44. Latin America Opioid-Induced Constipation (OIC) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 45. Latin America Opioid-Induced Constipation (OIC) Treatment Market Share by Type (2016-2027)
    Figure 46. Latin America Opioid-Induced Constipation (OIC) Treatment Market Share by Application (2016-2027)
    Figure 47. Latin America Opioid-Induced Constipation (OIC) Treatment Market Share by Country (2016-2027)
    Figure 48. Mexico Opioid-Induced Constipation (OIC) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 49. Brazil Opioid-Induced Constipation (OIC) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 50. Middle East & Africa Opioid-Induced Constipation (OIC) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 51. Middle East & Africa Opioid-Induced Constipation (OIC) Treatment Market Share by Type (2016-2027)
    Figure 52. Middle East & Africa Opioid-Induced Constipation (OIC) Treatment Market Share by Application (2016-2027)
    Figure 53. Middle East & Africa Opioid-Induced Constipation (OIC) Treatment Market Share by Country (2016-2027)
    Figure 54. Turkey Opioid-Induced Constipation (OIC) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 55. Saudi Arabia Opioid-Induced Constipation (OIC) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 56. UAE Opioid-Induced Constipation (OIC) Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 57. GlaxoSmithKline Revenue Growth Rate in Opioid-Induced Constipation (OIC) Treatment Business (2016-2021)
    Figure 58. AstraZeneca Revenue Growth Rate in Opioid-Induced Constipation (OIC) Treatment Business (2016-2021)
    Figure 59. Pfizer Revenue Growth Rate in Opioid-Induced Constipation (OIC) Treatment Business (2016-2021)
    Figure 60. S.L.A. Pharma Revenue Growth Rate in Opioid-Induced Constipation (OIC) Treatment Business (2016-2021)
    Figure 61. AIKO Biotechnology Revenue Growth Rate in Opioid-Induced Constipation (OIC) Treatment Business (2016-2021)
    Figure 62. Cubist Pharmaceuticals Revenue Growth Rate in Opioid-Induced Constipation (OIC) Treatment Business (2016-2021)
    Figure 63. Salix Pharmaceuticals Revenue Growth Rate in Opioid-Induced Constipation (OIC) Treatment Business (2016-2021)
    Figure 64. Takeda Pharmaceutical Revenue Growth Rate in Opioid-Induced Constipation (OIC) Treatment Business (2016-2021)
    Figure 65. Bottom-up and Top-down Approaches for This Report
    Figure 66. Data Triangulation
    Figure 67. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
GlaxoSmithKline
AstraZeneca
Pfizer
S.L.A. Pharma
AIKO Biotechnology
Cubist Pharmaceuticals
Salix Pharmaceuticals
Takeda Pharmaceutical
Frequently Asked Questions
Opioid-Induced Constipation (OIC) Treatment report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Opioid-Induced Constipation (OIC) Treatment report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Opioid-Induced Constipation (OIC) Treatment report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

3D Map System

Market Analysis and Insights: Global 3D Map System Market
The global 3D Map System  ... Read More